Premium
Role of the hepatocyte nuclear factor 4α in control of the pregnane X receptor during fetal liver development
Author(s) -
Kamiya Akihide,
Inoue Yusuke,
Gonzalez Frank J.
Publication year - 2003
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1053/jhep.2003.50212
Subject(s) - pregnane x receptor , hepatocyte nuclear factor 4 , biology , nuclear receptor , hepatocyte nuclear factors , hepatocyte , constitutive androstane receptor , fetus , transcription factor , xenobiotic , endocrinology , medicine , gene , genetics , biochemistry , pregnancy , in vitro , enzyme
The fetal liver, the major site of hematopoiesis during embryonic development, acquires additional functions near birth. Among the important liver functions is the response to xenobiotic exposure due to expression of several cytochromes P450 (CYP) and drug efflux transporters. Expression of these genes is regulated by nuclear receptors such as the pregnane X receptor (PXR). In this study, regulation of xenobiotic responses during fetal liver development was analyzed using a fetal hepatocyte primary culture system derived from embryonic day 15 (E15) livers. Hepatocyte nuclear factor (HNF) 4α regulates the expression of many genes preferentially in the liver. Expression of several xenobiotic response genes as well as HNF4α was increased in fetal hepatocytes stimulated by the hepatic maturation factors oncostatin M (OSM) and Matrigel. To determine the contribution of HNF4α to xenobiotic responses in the fetal liver, fetal hepatocytes containing floxed HNF4α alleles were cultured and the HNF4α gene was inactivated by infection with an adenovirus containing the Cre gene. Expression of CYP3A11 and PXR was suppressed by inactivation of HNF4α. An HNF4α binding site was characterized in the PXR promoter and found to be required for activation of the PXR promoter in fetal hepatocytes. In conclusion, HNF4α is the key transcription factor regulating responses to xenobiotics through activation of the PXR gene during fetal liver development.